Results 101 to 110 of about 3,264 (192)

The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.

open access: yesPLoS ONE, 2012
Bullous pemphigoid is an autoimmune blistering skin disease associated with autoantibodies against the dermal-epidermal junction. Passive transfer of antibodies against BP180/collagen (C) XVII, a major hemidesmosomal pemphigoid antigen, into neonatal ...
Eva Oswald   +7 more
doaj   +1 more source

Ex vivo granulocyte-activation capacity of BP180/CXVII-specific rabbit IgG antibodies.

open access: yes, 2012
(A) Leukocytes (3×107/ml) were stimulated with rabbit ICs consisting of 5 µg recombinant BP180/CXVII/well and 100 µl of 50-fold diluted BP180/CXVII-specific rabbit serum. ROS production was measured over a period of 60 min. Data are represented as mean ±
Claus-Werner Franzke (185138)   +7 more
core   +1 more source

Image_1_Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.TIF

open access: yes, 2019
Bullous pemphigoid (BP) is a common autoimmune blistering disease in which autoantibodies target the hemidesmosomal components BP180 and/or BP230 in basal keratinocytes.
Yosuke Mai (630844)   +3 more
core   +1 more source

074 There are two isoforms of BP180 in the mouse brain [PDF]

open access: yesJournal of Investigative Dermatology, 2020
J. Chen   +11 more
openaire   +1 more source

Diagnostic challenge: Juvenile bullous pemphigoid with a negative BP180 ELISA

open access: yesPediatric Dermatology
Abstract Bullous pemphigoid (BP) is an autoimmune blistering disease primarily affecting the elderly, whereas cases of juvenile BP are rare. Both types of BP are typically mediated by autoantibodies targeting the NC16A region of BP180; however, a small subset of adult patient sera react to other regions of the protein.
Janet A. Fairley   +4 more
openaire   +2 more sources

Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid [PDF]

open access: yes, 2012
BACKGROUND: Bullous pemphigoid (BP) is an autoimmune subepidermal bullous disease associated with autoantibodies against BP180 and BP230. Enzyme-linked immunosorbent assay (ELISA) is a sensitive tool for the detection of immunoglobulin G (IgG) anti-BP180
김수찬, 김송이, 김신영
core  

A rare case of keloid combined with bullous pemphigoid

open access: yesDermatology Reports
Keloids and bullous pemphigoid (BP) are two clinically and pathophysiologically distinct dermatologic disorders – the former involves abnormal scar formation due to excess collagen deposition, while the latter is an autoimmune blistering disease.
Ying Zhang   +6 more
doaj   +1 more source

Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180

open access: yes, 2011
Mucous membrane pemphigoid (MMP) is a rare autoimmune, subepidermal, bullous disease characterized by erosive lesions on the mucous membranes and skin. MMP reacts with various target antigens including BP180, laminin-332, β4 integrin, α6 integrin or type
김수찬, 이상은
core   +1 more source

유사천포창 환자의 자가항체가 각질형성세포의 세포고사와 BP180 발현에 미치는 영향

open access: yes, 2015
의과대학/석사Bullous pemphigoid (BP) is an autoimmune blistering disorder characterized by tense inflammatory subepidermal bullae. BP is caused by binding of IgG autoantibodies to hemidesmosomal proteins BP180 and BP230.
김태형
core  

Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.

open access: yes, 2008
Autoantibodies to basement membrane proteins BP180 and BP230 are characteristic of bullous pemphigoid and other subepidermal immunobullous disorders.
Vanessa Venning   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy